Track topics on Twitter Track topics that are important to you
Colorectal cancer is the third most common cause of cancer-related mortality worldwide. Scientists at The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust have found that colorectal cancer tumors can switch off expression of a cell surface molecule that is a key target of immunotherapy, which stops the treatment from working.
The post Colon Cancer Changes Its Spots to Dodge Latest Immunotherapies appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Article: Colon Cancer Changes Its Spots to Dodge Latest ImmunotherapiesNEXT ARTICLE
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...